Cochlear | COH - Marktkapitalisierung

Aktienkurs
172.10
Täglich Wechseln
-1.34 -0.77%
Monatlich
-6.17%
Jährlich
-31.32%
Q2 Prognose
168.61




Marktkapitalisierung Veränderung Datum
Ansell USD 3.36B 450.92M 2025-12
Avita Medical AUD 105.47M 35.32M 2025-12
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Fisher Paykel Healthcare NZD 21.76B 2.1B 2025-12
Integral Diagnostics AUD 1.08B 457.31M 2024-12
Mayne Pharma AUD 252.67M 153.55M 2025-12
Mesoblast USD 2.3B 25.17M 2026-04
Monash IVF AUD 286.38M 11.69M 2025-12
Nanosonics AUD 1.2B 25.43M 2025-12
Polynovo AUD 849.74M 24.18M 2025-12
Ramsay Health Care AUD 7.93B 537.83M 2025-12
Regis Healthcare AUD 2.1B 260.38M 2025-12
ResMed USD 52.52B 12.57B 2025-12
Sigma Healthcare AUD 2.7B 1.99B 2026-04
Somnomed AUD 79.04M 27.72M 2023-06
Sonic Healthcare AUD 11.17B 1.7B 2025-12
Telix Pharmaceuticals AUD 5.07B 5.81B 2025-12